Vanguard
http://www.vanguard.com/Vanguard, an investment management company, offers mutual funds and other financial products and services to institutional and individual investors worldwide.
View Older Stories View More Recent Stories
-
BRP Group (BRP) Announces Acquisition of EBSME, LLC
-
BRP Group, Inc. Announces Acquisition of EBSME, LLC
-
BRP Group, Inc. Announces Acquisition of EBSME, LLC
-
CollegeInvest announces a reduction in fees for its Direct Portfolio College Savings Plan
-
Wolters Kluwer Vanguard Software Welcomes Newest Customer Hy Cite Enterprises
-
Vanguard Announces Plans to Launch Two New Active Bond Funds
-
Form 485APOS VANGUARD MALVERN FUNDS
-
Form 497 VANGUARD WELLINGTON FUND
-
Republic Tobacco Rebrands as Republic Brands, Establishes New Vision to Meet Demands of the Evolving Roll-Your-Own Market
-
UPDATE: Goldman Sachs Upgrades United Microelectronics Corp (2303:TT) (UMC) to Conviction Buy
-
TrinaTracker stability ratified with comprehensive wind tunnel test
-
China's efforts to calm investor jitters help markets rebound
-
Form N-CSRS VANGUARD OHIO TAX-FREE For: May 31
-
Form N-CSRS VANGUARD NEW YORK TAX-FR For: May 31
-
Form N-CSRS VANGUARD CALIFORNIA TAX- For: May 31
-
Form N-CSRS VANGUARD MASSACHUSETTS For: May 31
-
Form N-CSRS VANGUARD NEW JERSEY TAX- For: May 31
-
Form N-CSRS VANGUARD PENNSYLVANIA For: May 31
-
Form 13F-HR Vanguard Capital Wealth For: Jun 30
-
Form N-CSRS VANGUARD WELLINGTON FUND For: May 31
-
AdPredictive Announces Travis Rhoades as Executive Vice President of Data Analytics and Intelligence
-
Delivery Hero Partners with Eco-Products to Launch Sustainable Packaging Program Across Globe
-
Global Medical Alert/Personal Emergency Response System Market Expected to Reach US$ 13,689.8 Million by 2027, With a CAGR Of 7.4% | Growth Market Reports
-
Yext Enhances its AI Search Platform with Phoenix Algorithm Update, Test Search Tools, Data Connectors, and New Apps Framework
-
Global ETFs draw record inflows in first half of 2021
-
Briggs & Stratton Launches New Vanguard® 10kWh Commercial Lithium-Ion Battery Pack
-
Litmus Debuts Speakers For Litmus Live 2021
-
MBO Partners® Announces New CFO to Advance Platform and Fuel Growth
-
DT Midstream to Open National Headquarters in Downtown Detroit
-
Vanguard Announces Cash Distributions for the Vanguard ETFs
-
Alexandria Real Estate Equities, Inc., at the Vanguard of Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand from the Life Science Industry, Reports: 2Q21 and 1H21 Net Income
-
Da Volterra Announces First Patient Randomized in Phase 3 Clinical Trial Evaluating the Gut Microbiome Protector DAV132 in Patients with Hematologic Malignancies
-
IonQ Positions Itself for Continued Industry Leadership with a String of Strategic Hires
-
KDD 2021 Data Science Conference Welcomes Singapore Senior Minister of State Dr. Janil Puthucheary for Opening Address
-
Vanguard Announces Cash Distributions for the Vanguard ETFs
-
Dr. David A. Thomas Joins Vanguard's Board of Directors
-
BRP Group (BRP) Acquires The Capital Group
-
BRP Group, Inc. Enters Into Agreement to Acquire The Capital Group
-
BRP Group, Inc. Enters Into Agreement to Acquire The Capital Group
-
Form 497 VANGUARD WORLD FUND
-
BRP Group (BRP) Acquires FounderShield
-
BRP Group, Inc. Enters Into Agreement to Acquire FounderShield LLC
-
BRP Group, Inc. Enters Into Agreement to Acquire FounderShield LLC
-
Churchill Capital Corp IV Chairman and CEO Michael Klein and Lucid Motors CEO and CTO Peter Rawlinson to Host Investor Call Today at 11:30 AM to Discuss Lucid Business Combination and Importance of Vo
-
In a Post #BlackTikTokStrike World, Creators of Color Have a Home at TipSnaps, the First Black-owned Creator Platform
-
Churchill Capital Corp IV to Adjourn and Reconvene Special Meeting of Stockholders to Friday, July 23, 2021 to Allow Stockholders More Time to Vote on One Remaining Required Proposal for the Business
-
Form 485APOS VANGUARD WHITEHALL FUNDS
-
Form 485APOS VANGUARD SPECIALIZED
-
Adagene Inc. (ADAG) Announces Clinical Trial Collaboration With Merck (MRK) to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs in Combination Therapy with KEYTRUDA
-
Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)


